180 Life Sciences Corp.ATNF

時価総額

$1255.9万

PER

	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Research and development	-	-	-	2	1	2
Research and development - related parties	-	-	-	75,633	3	240,731
General and administrative	343,884	599,075	1	3	11	15
General and administrative - related parties	-	-	-	185,848	462,580	5,612
Total Operating Expenses	-	-	-	6	16	18
Loss From Operations	-343,884	-599,075	-1,208,943	-5,648,112	-15,641,003	-17,897,965
Gain on settlement of liabilities	-	-	-	-	926,829	-
Other expense	-	-	-	15,334	-146,822	-
Interest expense	-	-	-	-	-	26,667
Loss on extinguishment of convertible notes payable, net	-	-	-	-2,580,655	-9,737	-
Loss on goodwill impairment	-	-	-	-	-	34
Loss on IP R&D impairment	-	-	-	-	-	-3,342,084
Change in fair value of derivative liabilities	-	-	-	2	5	-15,144,986
Change in fair value of accrued issuable equity	-	-	-	-	9,405	-
Offering costs allocated to warrant liabilities	-	-	-	-	604,118	-
Total Other Expense, Net	663,017	-	-	-5,256,373	-4,706,849	-21,771,043
Loss Before Income Taxes	319,133	1	165,955	-10,904,485	-20,347,852	-39,669,008
Income tax benefit	195,369	413,191	257,255	-20,427	-23,204	-942,749
Net Loss Attributable to Common Stockholders	-	-	-	-12,006,760	-20,324,648	-38,726,259
Foreign currency translation adjustments	-	-	-	484,083	180,554	-3,702,963
Total Comprehensive Loss	-	-	-	-10,399,975	-20,144,094	-42,429,222
Basic and Diluted Net Loss per Common Share (in Dollars per share)	0.04	0.25	-0.02	-	-	-20.38